297
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer

, , , &
Pages 751-763 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vladimir Avkshtol & Nicholas G Zaorsky. (2016) A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Research and Reports in Urology 8, pages 145-158.
Read now
Nicholas George Zaorsky, Mark D Hurwitz, Adam P Dicker, Timothy N Showalter & Robert B Den. (2015) Is robotic arm stereotactic body radiation therapy ‘virtual high-dose rate brachytherapy’ effective for prostate cancer? An analysis of comparative effectiveness using published data. Expert Review of Medical Devices 12:3, pages 317-327.
Read now

Articles from other publishers (5)

Hui Xue, Bin Qiu, Hao Wang, Ping Jiang, Olga Sukocheva, Ruitai Fan, Lixiang Xue & Junjie Wang. (2021) Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy. Cancers 13:14, pages 3493.
Crossref
Nicholas G. Zaorsky, Brian J. Davis, Paul L. Nguyen, Timothy N. Showalter, Peter J. Hoskin, Yasuo Yoshioka, Gerard C. Morton & Eric M. Horwitz. (2017) The evolution of brachytherapy for prostate cancer. Nature Reviews Urology 14:7, pages 415-439.
Crossref
Nicholas G. Zaorsky, Talha Shaikh, Karen Ruth, Pankaj Sharda, Shelly B. Hayes, Mark L. Sobczak, Mark A. Hallman, Marc C. Smaldone, David Y.T. Chen & Eric M. Horwitz. (2017) Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy. Clinical Genitourinary Cancer 15:2, pages 326-335.e3.
Crossref
Nicholas G. Zaorsky & Eric M. Horwitz. 2016. Prostate Cancer. Prostate Cancer 399 411 .
Berardino De Bari, Antonino Daidone & Filippo Alongi. (2015) Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature. Critical Reviews in Oncology/Hematology 94:3, pages 360-370.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.